SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-12-000038
Filing Date
2012-05-21
Accepted
2012-05-21 14:11:41
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 708154
2 exhibit31-1.htm EX-31.1 14777
3 exhibit32-1.htm EX-32.1 5421
4 exhibit99-1.htm EX-99.1 9243
  Complete submission text file 0001424884-12-000038.txt   2176112

Data Files

Seq Description Document Type Size
5 tpiv-20120331.xml EX-101.INS 202983
6 tpiv-20120331.xsd EX-101.SCH 14263
7 tpiv-20120331_cal.xml EX-101.CAL 34108
8 tpiv-20120331_def.xml EX-101.DEF 86178
9 tpiv-20120331_lab.xml EX-101.LAB 109224
10 tpiv-20120331_pre.xml EX-101.PRE 102349
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 12857883
SIC: 2834 Pharmaceutical Preparations